Vivos Therapeutics Files 2024 10-K
Ticker: VVOS · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1716166
| Field | Detail |
|---|---|
| Company | Vivos Therapeutics, Inc. (VVOS) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
Vivos Therapeutics 2024 10-K is in. Check financials for product/service revenue & capital changes.
AI Summary
Vivos Therapeutics, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 31, 2025. The company, based in Littleton, Colorado, operates in the Surgical & Medical Instruments & Apparatus industry. The filing covers financial data for the fiscal years 2024, 2023, and 2022, detailing product and service revenues, as well as common stock, additional paid-in capital, and retained earnings.
Why It Matters
This filing provides a comprehensive overview of Vivos Therapeutics' financial performance and position for the fiscal year 2024, offering insights into its revenue streams and capital structure for investors and stakeholders.
Risk Assessment
Risk Level: medium — As a publicly traded company filing a 10-K, there are inherent risks associated with financial reporting and market performance, though no specific major risks are highlighted in this header data.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Fiscal Year (Comparative period)
- 2022 — Fiscal Year (Comparative period)
Key Players & Entities
- Vivos Therapeutics, Inc. (company) — Filer
- 0001716166 (company) — Central Index Key
- 3841 (company) — Standard Industrial Classification Code
- Littleton, CO (location) — Business Address City/State
- 20241231 (date) — Fiscal Year End
- 20250331 (date) — Filing Date
FAQ
What were Vivos Therapeutics' total revenues for the fiscal year ended December 31, 2024?
The provided header data does not contain specific dollar amounts for total revenues for the fiscal year ended December 31, 2024. It indicates that product and service revenues were reported for 2024.
What is Vivos Therapeutics' primary industry classification?
Vivos Therapeutics, Inc. is classified under SIC code 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
When did Vivos Therapeutics file its 10-K for the fiscal year 2024?
Vivos Therapeutics filed its 10-K for the fiscal year ended December 31, 2024, on March 31, 2025.
What are the key financial statement components reported for the fiscal years 2022, 2023, and 2024?
The filing header indicates reporting for Common Stock, Additional Paid-In Capital, and Retained Earnings for the fiscal years ending December 31, 2022, 2023, and 2024.
Where is Vivos Therapeutics, Inc. headquartered?
Vivos Therapeutics, Inc. is headquartered in Littleton, Colorado, with its business address listed as 7921 Southpark Plaza, Suite 210.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Vivos Therapeutics, Inc. (VVOS).